The planned extension of the production capacity for the single-use tests was projected to be implemented in a step-by-step manner, with the final step, a fully automated production line, estimated to be achieved in 2021-2022. Following the decision made today this investment will be brought forward so that Calmark can scale up the production volume faster but also achieve significantly reduced manufacturing costs for the single-use tests more quickly.
"I am delighted that SEB gives us this opportunity to bring the final step of the automation forward. Achieving lower manufacturing costs sooner will enable volume sales in the countries where we can do the greatest good," says Anna Söderlund, CEO. "We are looking forward to being able to meet a great demand for our products."
This information is information that Calmark Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 16:50 CEST on 16 April 2020.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
